- Jonathan Poyer
Biotech Acquisitions Off to the Races
Only one full week into 2023 and already we have seen 3 acquisitions in the biotech space:
CinCor Pharma to be Acquired by AstraZeneca | CinCor Pharma Inc
Ipsen to acquire Albireo accelerating growth in rare disease with treatments for several pediatric liver diseases | Albireo (albireopharma.com)
Italy's Chiesi Farmaceutici to buy Amryt Pharma in a $1.48 billion deal (yahoo.com)
There were 13 M&A deals greater than $250M in 2022. It looks like we are going to have an exciting 2023.
The JPM Healthcare Conference kicks off today. Let's see what else unfolds over the rest of the week!